Thrombolysis of occluded arterial bypass grafts. 1988

G A Gardiner
Cardiovascular and Interventional Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107.

Seventy-eight patients with 87 thrombosed grafts or arteries were treated by direct intraarterial infusion of streptokinase or urokinase. Initial success rate in treatment of occluded grafts (60%) was nearly identical to native artery occlusion (63%), and nearly twice as high for urokinase (76%) compared with streptokinase (43%). There was no statistically significant difference in complication rates between native vessel occlusion and thrombosed grafts, or between urokinase- and streptokinase-treated groups. Nineteen of 29 grafts (66%) remain patent after an average 11-month followup.

UI MeSH Term Description Entries
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006083 Graft Occlusion, Vascular Obstruction of flow in biological or prosthetic vascular grafts. Graft Restenosis, Vascular,Vascular Graft Occlusion,Vascular Graft Restenosis,Graft Restenoses, Vascular,Occlusion, Vascular Graft,Restenosis, Vascular Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator

Related Publications

G A Gardiner
August 1997, Acta chirurgica Belgica,
G A Gardiner
January 1991, Seminars in thrombosis and hemostasis,
G A Gardiner
January 1991, Seminars in thrombosis and hemostasis,
G A Gardiner
December 1993, Journal of vascular surgery,
G A Gardiner
October 1994, Journal of vascular surgery,
G A Gardiner
January 2010, Acta chirurgica Belgica,
G A Gardiner
January 1992, The British journal of surgery,
G A Gardiner
June 1994, The Journal of cardiovascular surgery,
G A Gardiner
May 1994, American journal of surgery,
Copied contents to your clipboard!